Anti-PI16/ CD364/ CRISP9 functional antibody

Anti-PI16/ CD364/ CRISP9 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to PI16/PI16 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0405-Ab-1/ GM-Tg-hg-SE0405-Ab-2Anti-Human PI16 monoclonal antibodyHuman
GM-Tg-rg-SE0405-Ab-1/ GM-Tg-rg-SE0405-Ab-2Anti-Rat PI16 monoclonal antibodyRat
GM-Tg-mg-SE0405-Ab-1/ GM-Tg-mg-SE0405-Ab-2Anti-Mouse PI16 monoclonal antibodyMouse
GM-Tg-cynog-SE0405-Ab-1/ GM-Tg-cynog-SE0405-Ab-2Anti-Cynomolgus/ Rhesus macaque PI16 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0405-Ab-1/ GM-Tg-felg-SE0405-Ab-2Anti-Feline PI16 monoclonal antibodyFeline
GM-Tg-cang-SE0405-Ab-1/ GM-Tg-cang-SE0405-Ab-2Anti-Canine PI16 monoclonal antibodyCanine
GM-Tg-bovg-SE0405-Ab-1/ GM-Tg-bovg-SE0405-Ab-2Anti-Bovine PI16 monoclonal antibodyBovine
GM-Tg-equg-SE0405-Ab-1/ GM-Tg-equg-SE0405-Ab-2Anti-Equine PI16 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0405-Ab-1/ GM-Tg-hg-SE0405-Ab-2; GM-Tg-rg-SE0405-Ab-1/ GM-Tg-rg-SE0405-Ab-2;
GM-Tg-mg-SE0405-Ab-1/ GM-Tg-mg-SE0405-Ab-2; GM-Tg-cynog-SE0405-Ab-1/ GM-Tg-cynog-SE0405-Ab-2;
GM-Tg-felg-SE0405-Ab-1/ GM-Tg-felg-SE0405-Ab-2; GM-Tg-cang-SE0405-Ab-1/ GM-Tg-cang-SE0405-Ab-2;
GM-Tg-bovg-SE0405-Ab-1/ GM-Tg-bovg-SE0405-Ab-2; GM-Tg-equg-SE0405-Ab-1/ GM-Tg-equg-SE0405-Ab-2
Products NameAnti-PI16 monoclonal antibody
Formatmab
Target NamePI16
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-PI16 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0405-Ag-1Recombinant multi-species PI16/ CD364/ CRISP9 protein
    ORF Viral VectorpGMLPm003994mouse Pi16 Lentivirus plasmid
    ORF Viral VectorvGMLPm003994mouse Pi16 Lentivirus particle


    Target information

    Target IDGM-SE0405
    Target NamePI16
    Gene ID221476,74116,294312,719301,481769,101082151,507058,100053848
    Gene Symbol and Synonyms1200009H11Rik,CD364,Cripi,CRISP9,MSMBBP,PI-16,PI16,PSPBP
    Uniprot AccessionQ6UXB8,Q58D34
    Uniprot Entry NamePI16_HUMAN,PI16_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000164530
    Target ClassificationN/A

    The target: PI16, gene name: PI16, also named as CD364, CRISP9, MSMBBP, PSPBP. Predicted to enable peptidase inhibitor activity. Predicted to be involved in negative regulation of peptidase activity. Predicted to act upstream of or within negative regulation of cell growth involved in cardiac muscle cell development. Predicted to be active in extracellular space. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.